Literature DB >> 4914980

Observations and comments concerning the isolation of group B beta-hemolytic streptococci from human sources.

P D Finn, F A Holden.   

Abstract

A marked increase in the isolation of Group B streptococci from patients in the University Hospital, Saskatoon, has been noted over the past four years, and no change in technical methods has been found to explain this increase. Group B streptococci have been isolated from 242 patients, in 53 of whom the streptococcus was considered the cause of the infection. Infections occurred predominantly in the urinary tract, female genital tract and upper respiratory tract. There was a low incidence of infections in newborn infants, and only four infections were in patients under 1 year old. Infections were more frequent in women than men and in patients over 40 years of age. No particular affinity of Group B streptococci for diabetics was demonstrated.

Entities:  

Mesh:

Year:  1970        PMID: 4914980      PMCID: PMC1930381     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  9 in total

1.  [STREPTOCOCCUS AGALACTIAE AS THE CAUSATIVE AGENT IN INFANTILE MENINGITIS].

Authors:  G KEXEL; S SCHOENBOHM
Journal:  Dtsch Med Wochenschr       Date:  1965-02-05       Impact factor: 0.628

2.  HUMAN INFECTIONS CAUSED BY NON-GROUP A OR D STREPTOCOCCI.

Authors:  J A REINARZ; J P SANFORD
Journal:  Medicine (Baltimore)       Date:  1965-01       Impact factor: 1.889

3.  Use of autoclaved extracts of hemolytic streptococci for serological grouping.

Authors:  L A RANTZ; E RANDALL
Journal:  Stanford Med Bull       Date:  1955-05

4.  Beta hemolytic streptococcus group B associated with problems of the perinatal period.

Authors:  M HOOD; A JANNEY; G DAMERON
Journal:  Am J Obstet Gynecol       Date:  1961-10       Impact factor: 8.661

5.  Penicillin Therapy in Acute Bacterial Endocarditis.

Authors:  A Dolphin; R Cruickshank
Journal:  Br Med J       Date:  1945-06-30

6.  Neonatal meningitis due to Streptococcus agalactiae.

Authors:  H E Jones; C H Howells
Journal:  Postgrad Med J       Date:  1968-07       Impact factor: 2.401

7.  Purpura fulminans with group B Beta-hemolytic streptococcal endocarditis.

Authors:  W H Hall
Journal:  Arch Intern Med       Date:  1965-10

8.  [Studies on the occurrence of B streptococci in the puerperium].

Authors:  G Kexel; K J Beck
Journal:  Geburtshilfe Frauenheilkd       Date:  1965-11       Impact factor: 2.915

9.  Unusual occurrence of neonatal meningitis due to group B beta-hemolytic streptococci.

Authors:  R H Winterbauer; R Fortuine; T C Eickhoff
Journal:  Pediatrics       Date:  1966-10       Impact factor: 7.124

  9 in total
  7 in total

1.  Fatal neonatal meningitis due to group B streptococci.

Authors:  B Chattopadhyay
Journal:  Postgrad Med J       Date:  1975-04       Impact factor: 2.401

2.  Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources.

Authors:  C J Baker; B J Webb; F F Barrett
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

3.  Carrier rate of group B streptococci with relevance to neonatal infections.

Authors:  L Bevanger
Journal:  Infection       Date:  1974       Impact factor: 3.553

Review 4.  Group B streptococci in human disease.

Authors:  M J Patterson; A El Batool Hafeez
Journal:  Bacteriol Rev       Date:  1976-09

5.  Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis).

Authors:  H W Wilkinson; R R Facklam; E C Wortham
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

6.  Group B streptococcal vertebral osteomyelitis in an adult.

Authors:  G Elhanan; R Raz
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

7.  Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.

Authors:  G W Fischer; G H Lowell; M H Crumrine; J W Bass
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.